BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20923254)

  • 1. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
    Nguyen C; Christensen JM; Ayres JW
    Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid.
    Xu M; Sun M; Qiao H; Ping Q; Elamin ES
    Int J Pharm; 2014 Jul; 468(1-2):165-71. PubMed ID: 24746693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine.
    Cantor SL; Hoag SW; Augsburger LL
    Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a potential colonic drug delivery system of mesalamine.
    Gohel MC; Parikh RK; Nagori SA; Dabhi MR
    Pharm Dev Technol; 2008; 13(5):447-56. PubMed ID: 18798122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
    Patel MM; Amin AF
    Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
    Kumar RV; Sinha VR
    Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compression of coated drug beads for sustained release tablet of glipizide: formulation, and dissolution.
    Nguyen C; Christensen JM; Ayres JW
    Pharm Dev Technol; 2014 Feb; 19(1):10-20. PubMed ID: 23259589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of spray-dried chitosan acetate and ethylcellulose as compression coats for colonic drug delivery: effect of swelling on triggering in vitro drug release.
    Nunthanid J; Luangtana-anan M; Sriamornsak P; Limmatvapirat S; Huanbutta K; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2009 Feb; 71(2):356-61. PubMed ID: 18762255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel polymeric film coatings for colon targeting: Drug release from coated pellets.
    Karrout Y; Neut C; Wils D; Siepmann F; Deremaux L; Flament MP; Dubreuil L; Desreumaux P; Siepmann J
    Eur J Pharm Sci; 2009 Jun; 37(3-4):427-33. PubMed ID: 19491034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery.
    Freire C; Podczeck F; Veiga F; Sousa J
    Drug Dev Ind Pharm; 2010 Feb; 36(2):161-72. PubMed ID: 19678749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatically degraded Eurylon 6 HP-PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients.
    Karrout Y; Neut C; Siepmann F; Wils D; Ravaux P; Deremaux L; Flament MP; Dubreuil L; Lemdani M; Desreumaux P; Siepmann J
    J Pharm Pharmacol; 2010 Dec; 62(12):1676-84. PubMed ID: 21054393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--part 1--acetaminophen.
    Cantor SL; Hoag SW; Augsburger LL
    Drug Dev Ind Pharm; 2009 Mar; 35(3):337-51. PubMed ID: 18798034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
    Khan MZ; Stedul HP; Kurjaković N
    Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics.
    Schellekens RC; Baltink JH; Woesthuis EM; Stellaard F; Kosterink JG; Woerdenbag HJ; Frijlink HW
    Pharm Dev Technol; 2012; 17(1):40-7. PubMed ID: 20923321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release.
    Andreas CJ; Chen YC; Markopoulos C; Reppas C; Dressman J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):39-50. PubMed ID: 26391972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
    Asghar LF; Chandran S
    Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.